Clinical Report: Treatment Approaches and Survival Rates in Older Adults with ICC
Overview
This study evaluates treatment patterns and survival outcomes in older adults with intrahepatic cholangiocarcinoma (ICC) using data from the National Cancer Database. It highlights significant differences in treatment approaches between elderly and younger patients.
Background
Intrahepatic cholangiocarcinoma (ICC) is a rare and aggressive malignancy primarily affecting older adults, yet this population is often underrepresented in clinical trials. The rising incidence of ICC necessitates a better understanding of treatment strategies tailored to older patients, who may have different responses and tolerances to therapies compared to younger cohorts.
Data Highlights
Parameter
Elderly Patients (>65 years)
Younger Patients (≤65 years)
Trimodality therapy
8.8%
14.4%
Surgery plus chemotherapy/radiotherapy
33.2%
41.5%
Surgery alone
58.0%
44.1%
Chemotherapy-based treatment (inoperable)
Less likely
More likely
Radiotherapy alone (inoperable)
7.2%
2.8%
Key Findings
Elderly patients were less likely to receive trimodality therapy compared to younger patients.
In operable cases, elderly patients were more likely to undergo surgery alone.
Among nonsurgical elderly patients, chemotherapy plus radiotherapy improved 1-year and 2-year overall survival compared to chemotherapy alone.
Surgery was associated with significantly improved survival across all patients.
In the inoperable setting, the addition of radiation therapy was linked to better short-term survival outcomes.
Clinical Implications
Clinicians should consider age-related differences when developing treatment plans for older adults with ICC.
Conclusion
This analysis reveals significant disparities in treatment approaches for ICC based on age.
Related Resources & Content
A Review of Intrahepatic Cholangiocarcinoma: Epidemiology, Diagnosis, and Treatment
Management of Intrahepatic Cholangiocarcinoma: A Review of Current Evidence
Cholangiocarcinoma: Current Treatment Strategies and Future Directions
The Role of Surgery in the Management of Intrahepatic Cholangiocarcinoma
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
Treatment Patterns and Outcomes in Elderly Patients with Cholangiocarcinoma - ScienceDirect
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
Treatment Patterns and Outcomes in Elderly Patients with Cholangiocarcinoma - ScienceDirect
